PCNA and neoplasm: In order to evaluate proliferative tumor potential, two markers, namely, proliferating cell nuclear antigen (PCNA) and Ki-67 were studied in HPV- and EBV-associated malignancies, the results revealing their usefulness in estimating tumor aggressiveness [36,82].